Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Drug-induced dementia. Incidence, management and prevention.

Starr JM, Whalley LJ.

Drug Saf. 1994 Nov;11(5):310-7. Review.

PMID:
7873091
2.

Drug-induced cognitive impairment in the elderly.

Moore AR, O'Keeffe ST.

Drugs Aging. 1999 Jul;15(1):15-28. Review.

PMID:
10459729
3.

Drug-induced cognition disorders in the elderly: incidence, prevention and management.

Gray SL, Lai KV, Larson EB.

Drug Saf. 1999 Aug;21(2):101-22. Review.

PMID:
10456379
4.

Anticholinergic drug use and risk for dementia: target for dementia prevention.

Jessen F, Kaduszkiewicz H, Daerr M, Bickel H, Pentzek M, Riedel-Heller S, Wagner M, Weyerer S, Wiese B, van den Bussche H, Broich K, Maier W.

Eur Arch Psychiatry Clin Neurosci. 2010 Nov;260 Suppl 2:S111-5. doi: 10.1007/s00406-010-0156-4. Epub 2010 Oct 20.

PMID:
20960005
5.

[Drugs Effect on Cognition in the Elderly].

Brefel-Courbon C.

Therapie. 2015 Nov-Dec;70(6):523-6. doi: 10.2515/therapie/2015038. Epub 2015 Jul 28. Review. French.

PMID:
26220919
6.

Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.

Carrière I, Fourrier-Reglat A, Dartigues JF, Rouaud O, Pasquier F, Ritchie K, Ancelin ML.

Arch Intern Med. 2009 Jul 27;169(14):1317-24. doi: 10.1001/archinternmed.2009.229.

7.

Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia.

Lee EK, Lee YJ.

Int J Clin Pharm. 2013 Oct;35(5):711-8. doi: 10.1007/s11096-013-9793-9. Epub 2013 May 25.

PMID:
23708883
8.

Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.

Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, Faure S, Mazouz H, Temmar M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black S, Sato N.

Expert Rev Neurother. 2009 Sep;9(9):1413-31. doi: 10.1586/ern.09.89. Review.

PMID:
19769454
9.

Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study.

Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Goff DC Jr.

Arch Intern Med. 2009 Jul 13;169(13):1195-202. doi: 10.1001/archinternmed.2009.175.

10.

Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS).

Gallacher J, Elwood P, Pickering J, Bayer A, Fish M, Ben-Shlomo Y.

J Epidemiol Community Health. 2012 Oct;66(10):869-73. doi: 10.1136/jech-2011-200314. Epub 2011 Oct 27.

PMID:
22034632
11.

Centrally Active ACEIs and cognitive decline.

Asamura T, Ohrui T, Une K, Furukawa K, Arai H.

Arch Intern Med. 2010 Jan 11;170(1):107-8; author reply 108. doi: 10.1001/archinternmed.2009.464. No abstract available.

PMID:
20065207
12.

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia.

Yaffe K, Sawaya G, Lieberburg I, Grady D.

JAMA. 1998 Mar 4;279(9):688-95.

PMID:
9496988
13.

Prescription Opioids and Risk of Dementia or Cognitive Decline: A Prospective Cohort Study.

Dublin S, Walker RL, Gray SL, Hubbard RA, Anderson ML, Yu O, Crane PK, Larson EB.

J Am Geriatr Soc. 2015 Aug;63(8):1519-26. doi: 10.1111/jgs.13562.

14.

Designing appropriate clinical trials to assess ACEI use and cognitive decline in older adults with hypertension.

Todd S, McGuinness B, Passmore AP.

Arch Intern Med. 2010 Jan 11;170(1):107. doi: 10.1001/archinternmed.2009.463. No abstract available.

PMID:
20065208
15.

Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.

Poon IO.

Pharmacotherapy. 2008 Mar;28(3):366-75. doi: 10.1592/phco.28.3.366. Review.

PMID:
18294116
17.

Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study.

Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K.

BMJ. 2006 Feb 25;332(7539):455-9. Epub 2006 Feb 1.

18.

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J; WHIMS Investigators.

JAMA. 2003 May 28;289(20):2651-62.

PMID:
12771112
19.

Ocimum sanctum Linn. leaf extracts inhibit acetylcholinesterase and improve cognition in rats with experimentally induced dementia.

Giridharan VV, Thandavarayan RA, Mani V, Ashok Dundapa T, Watanabe K, Konishi T.

J Med Food. 2011 Sep;14(9):912-9. doi: 10.1089/jmf.2010.1516. Epub 2011 Aug 3.

PMID:
21812651
20.

Inappropriate treatments for patients with cognitive decline.

Robles Bayón A, Gude Sampedro F.

Neurologia. 2014 Nov-Dec;29(9):523-32. doi: 10.1016/j.nrl.2012.05.004. Epub 2012 Oct 9. Review. English, Spanish.

Supplemental Content

Support Center